Bausch Health Companies (BHC) Long-Term Investments (2009 - 2012)
Bausch Health Companies' (BHC) quarterly Long-Term Investments came in at $7.2 million in Q4 2012, down 21.84% quarter-over-quarter from $9.2 million in Q2 2011.
Bausch Health Companies (BHC) Long-Term Investments (2009 - 2012) Analysis & Trends
Bausch Health Companies has disclosed Long-Term Investments across 4 years of filings, most recently posting $7.2 million for Q4 2012.
- Long-Term Investments for Q4 2012 came in at $7.2 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2012 was $7.2 million (changed N/A YoY), and the FY2012 annual result was $7.2 million, changed N/A from the prior year.
- Long-Term Investments came in at $7.2 million for Q4 2012 at Bausch Health Companies, down from $9.2 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $80.0 million in Q1 2011 to a low of $2.1 million in Q4 2010.
- The 4-year median for Long-Term Investments is $9.2 million (2011), against an average of $17.6 million.
- Across the five-year window, Long-Term Investments slumped 81.91% in 2010 and declined 5.07% in 2011, its largest moves.
- Bausch Health Companies' Long-Term Investments stood at $11.5 million in 2009, then plunged by 81.91% to $2.1 million in 2010, then soared by 340.23% to $9.2 million in 2011, then retreated by 21.84% to $7.2 million in 2012.
- The last three Long-Term Investments figures came in at $7.2 million (Q4 2012), $9.2 million (Q2 2011), and $80.0 million (Q1 2011), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 1.32 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.33 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 26.36 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.90 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Bausch Health Companies | 1.91 Bn | 1.58 Bn | 2.48 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | 7.17 Mn |
| Jun 30, 2011 | 9.17 Mn |
| Mar 31, 2011 | 79.95 Mn |
| Dec 31, 2010 | 2.08 Mn |
| Sep 30, 2010 | 3.65 Mn |
| Jun 30, 2010 | 9.66 Mn |
| Dec 31, 2009 | 11.52 Mn |